---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "85Iyhk0HXN7OnvRXa43bE94NuyE9Kt/623JNFSAlp+zj+HO2ZXqGSvkWxJVksPGGryfB1W5cZTYwGvoQ/Zer+rsldk/7M8lSRe0oq0K/TcEW87MKP0nyVvf4JnazS/+8As9rhzbLKv9xb1g19M2cXJj1QljKvHmIjTiogGHFsB3U8WcX65vToFqREAD/r9OnaXRSt2B3+W7BOuvF41oDYdN+hh6L+VWuM3P6TLwzEgAuXEiU9PUyBNJWrSDCHPnIqgKQy7KUKYUhieL+SsbJn+cZE/uTgcq721BMJcHqKln61LjdRgORYDheW6n/mXivEaYkxDFRt+kv5NV/58QiqAmQPvXCGQM/HPcE8mbfqLw=;FmdA1zkIFlxZKPJy1m2Kvw=="
---

